Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Silvia Imbergamo
Bendamustine Plus Rituximab Is an Effective First-Line Treatment in Hairy Cell Leukemia Variant: A Report of Three Cases
Oncotarget
Oncology
Effect of Recombinant Activated Factor VII in Critical Bleeding: Clinical Experience of a Single Center
Clinical and Applied Thrombosis/Hemostasis
Medicine
Hematology
Related publications
Variant Form of Hairy Cell Leukemia
Clinical Case Reports
Medicine
A Unique Variant of Hairy Cell Leukemia in Japan.
Japanese Journal of Medicine
Treatment of Hairy Cell Leukemia During Pregnancy: Are Purine Analogues and Rituximab Viable Therapeutic Options
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Advances in the Treatment of Hairy Cell Leukemia
Journal of Hematology & Thromboembolic Diseases
A PHASE 3 STUDY OF ACALABRUTINIB PLUS BENDAMUSTINE AND RITUXIMAB IN ELDERLY (AGED ≥65 Years) TREATMENT-NAIVE PATIENTS WITH MANTLE CELL LYMPHOMA
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Brentuximab-Vedotin and Bendamustine Is a Feasible and Effective Drug Combination as First-Line Treatment of Hodgkin Lymphoma in the Elderly (Halo Trial)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Prognostic Role of Translocator Protein and Oxidative Stress Markers in Chronic Lymphocytic Leukemia Patients Treated With Bendamustine Plus Rituximab
Oncology Letters
Cancer Research
Oncology
Higher Expression Levels of Activation-Induced Cytidine Deaminase Distinguish Hairy Cell Leukemia From Hairy Cell Leukemia-Variant and Splenic Marginal Zone Lymphoma
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Retrospective Evaluation of Hairy Cell Leukemia Patients Treated With 3 Different First-Line Treatment Modalities in the Last Two Decades: A Single Center Experience
Turkish Journal of Haematology
Hematology
